Cargando…

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis

BACKGROUND: Patient outcomes were assessed based on a pre-biopsy ExoDx Prostate (EPI) score at 2.5 years of the 5-year follow-up of ongoing prostate biopsy Decision Impact Trial of the ExoDx Prostate (IntelliScore). METHODS: Prospective, blinded, randomized, multisite clinical utility study was cond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tutrone, Ronald, Lowentritt, Ben, Neuman, Brian, Donovan, Michael J., Hallmark, Elliot, Cole, T. Jeffrey, Yao, Yiyuan, Biesecker, Claire, Kumar, Sonia, Verma, Vinita, Sant, Grannum R., Alter, Jason, Skog, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449627/ https://www.ncbi.nlm.nih.gov/pubmed/37193776 http://dx.doi.org/10.1038/s41391-023-00675-1

Ejemplares similares

Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome
por: Kretschmer, Alexander, et al.
Publicado: (2022)

Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies
por: Margolis, Erik, et al.
Publicado: (2021)

Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2–10 ng/mL
por: Tutrone, Ronald, et al.
Publicado: (2020)

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy
por: McKiernan, James, et al.
Publicado: (2020)

Interim evaluation of insertable cardiac monitor signal quality in the LUX-Dx PERFORM study
por: Richards, M, et al.
Publicado: (2023)

Understanding and Improving (18)F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer
por: Lowentritt, Benjamin H., et al.
Publicado: (2020)

Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies
por: Knezevic, Dejan, et al.
Publicado: (2013)

Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy
por: Kretschmer, Alexander, et al.
Publicado: (2022)

Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness
por: Ruiz-Plazas, Xavier, et al.
Publicado: (2021)

Focused issue on interstitial cystitis/bladder pain syndrome (IC/BPS) 2015: Part 2
por: Sant, Grannum R., et al.
Publicado: (2015)

Interstitial cystitis/bladder pain syndrome (IC/BPS) 2015: Part 1
por: Sant, Grannum R., et al.
Publicado: (2015)

Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy
por: Yan, Lei, et al.
Publicado: (2013)

Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia
por: Shore, Neal, et al.
Publicado: (2019)

DX centers
por: Munoz Merino, Elias
Publicado: (1994)

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
por: Nilsson, J, et al.
Publicado: (2009)

Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran
por: Azimi, Somayeh, et al.
Publicado: (2016)

Second Reply to Letter to the Editor re: “Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting”
por: White, Jay, et al.
Publicado: (2019)

Simultaneous enhancement of the beta–exo synergism and exo–exo synergism in Trichoderma reesei cellulase to increase the cellulose degrading capability
por: Fang, Hao, et al.
Publicado: (2019)

Interim Prostate-Specific Antigen: Predicting for Biochemical Failure During Salvage Radiation Therapy After Prostatectomy
por: Cardoso, Michael, et al.
Publicado: (2021)

Wandering stars: about planets and exo-planets : an introductory notebook
por: Cole, George H A
Publicado: (2006)

Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation
por: Guo, Zhaoxin, et al.
Publicado: (2015)

1962. TRAIL Level and ImmunoXpert™ Score Complement Molecular Viral Detection in the Classification of Febrile Children: An Interim Analysis From the AutoPilotDx-Study
por: Tenenbaum, Tobias, et al.
Publicado: (2018)

Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
por: Sant, Grannum R., et al.
Publicado: (2017)

Experimental overview - EXO
por: Ochoa, Ines
Publicado: (2020)

Exo- and endoglycosidases revisited
por: KOBATA, Akira
Publicado: (2013)

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
por: Page, Elizabeth C., et al.
Publicado: (2019)

Social determinants of prostate cancer in the Caribbean: a systematic review and meta-analysis
por: Brown, Catherine R., et al.
Publicado: (2018)

The Population Structure of Pseudomonas aeruginosa Is Characterized by Genetic Isolation of exoU+ and exoS+ Lineages
por: Ozer, Egon A, et al.
Publicado: (2019)

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines
por: Shore, Neal D., et al.
Publicado: (2020)

Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study
por: Rukstalis, Daniel, et al.
Publicado: (2018)

DE/DX TPC in cosmic data
por: Chevalier, L
Publicado: (1989)

Esterilidad femenina Dx. y Tx. /
por: Jiménez Jácome, José Alfredo
Publicado: (1987)

Calibration of the ALEPH dE/dx
por: Assmann, R W, et al.
Publicado: (1994)

Low utility of Oncotype DX® in the clinic
por: Ricks‐Santi, Luisel J., et al.
Publicado: (2017)

Anatomic Imaging of the Prostate
por: Bhavsar, Anil, et al.
Publicado: (2014)

Biomarkers in Prostate Cancer Epidemiology
por: Verma, Mukesh, et al.
Publicado: (2011)

A 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical Prostatectomy
por: Marrone, Michael, et al.
Publicado: (2015)

High detection rate in [(18)F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients
por: Watabe, Tadashi, et al.
Publicado: (2021)

Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)
por: Beck, Marcus, et al.
Publicado: (2021)

Preliminary results from the LUX‐Dx insertable cardiac monitor remote programming and performance (LUX‐Dx PERFORM) study
por: Stolen, Craig, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0a94rhe449hjbirbrl7r23v9rr